Literature DB >> 14563493

Characterisation of C5a receptor agonists from phage display libraries.

Stuart A Cain1, Adrian Higginbottom, Peter N Monk.   

Abstract

C5a des-Arg(74) has a 10- to 100-fold lower receptor binding affinity than intact C5a and is only a partial agonist. We have used phage display selection from randomly mutated C5a des-Arg(74) libraries to isolate variant proteins that can activate C5a receptors with similar potency to C5a. Here we explore the interactions of three variants (V1-3) with C5aR mutated at residues involved in the differential response. The mutant Asp(282)Arg-C5aR is preferentially activated by C5a des-Arg(74), probably due to repulsion between Arg(74) of C5a and the substituent Arg(282). In accordance with this hypothesis, V2 (with a polar C-terminus which has no Arg residue) but not V1 (with a C-terminal Arg residue at position 73) could activate Asp(282)Arg-C5aR. V3, with a very hydrophobic C-terminus, was the most potent agonist at Asp(282)Arg-C5aR. Arg(175) is a potential counterion for the C-terminal carboxylate of C5a. C5aR mutated to either Ala or Asp at this position lost nearly all responsiveness to both C5a and C5a des-Arg(74), suggesting that mutation of Arg(175) caused a non-specific loss of receptor conformation and a loss of signalling capacity. However, V3 could still activate Arg(175)Asp/Ala-C5aR with the same potency as wild-type C5aR, demonstrating that the mutant receptors retained high signalling capability and showed a specific loss of responsiveness. Thus C5a des-Arg(74) variants produced by phage display are potentially useful tools for the dissection of ligand-receptor interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563493     DOI: 10.1016/s0006-2952(03)00473-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Third extracellular loop (EC3)-N terminus interaction is important for seven-transmembrane domain receptor function: implications for an activation microswitch region.

Authors:  Soumendra Rana; Thomas J Baranski
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

2.  Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays In Vitro and In Vivo.

Authors:  Declan M Gorman; Xaria X Li; Colton D Payne; Cedric S Cui; John D Lee; K Johan Rosengren; Trent M Woodruff; Richard J Clark
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-17

Review 3.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

4.  Insights into the mechanism of C5aR inhibition by PMX53 via implicit solvent molecular dynamics simulations and docking.

Authors:  Phanourios Tamamis; Chris A Kieslich; Gregory V Nikiforovich; Trent M Woodruff; Dimitrios Morikis; Georgios Archontis
Journal:  BMC Biophys       Date:  2014-08-12       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.